IL283781A - Analosomes for the delivery of protein replacement therapeutics - Google Patents
Analosomes for the delivery of protein replacement therapeuticsInfo
- Publication number
- IL283781A IL283781A IL283781A IL28378121A IL283781A IL 283781 A IL283781 A IL 283781A IL 283781 A IL283781 A IL 283781A IL 28378121 A IL28378121 A IL 28378121A IL 283781 A IL283781 A IL 283781A
- Authority
- IL
- Israel
- Prior art keywords
- anellosomes
- therapeutic modalities
- protein replacement
- replacement therapeutic
- delivering protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US201862778861P | 2018-12-12 | 2018-12-12 | |
| PCT/US2019/065963 WO2020123795A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes for delivering protein replacement therapeutic modalities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL283781A true IL283781A (en) | 2021-07-29 |
Family
ID=69160356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL283781A IL283781A (en) | 2018-12-12 | 2021-06-07 | Analosomes for the delivery of protein replacement therapeutics |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220073950A1 (enExample) |
| EP (1) | EP3894569A2 (enExample) |
| JP (2) | JP2022513459A (enExample) |
| KR (1) | KR20210125990A (enExample) |
| CN (1) | CN114127303A (enExample) |
| AU (1) | AU2019395418A1 (enExample) |
| BR (1) | BR112021010925A2 (enExample) |
| CA (1) | CA3119814A1 (enExample) |
| IL (1) | IL283781A (enExample) |
| MX (1) | MX2021006945A (enExample) |
| WO (1) | WO2020123795A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018201160A1 (en) | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| CA3056801A1 (en) | 2017-04-28 | 2018-11-01 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
| MX2020003074A (es) | 2017-09-25 | 2020-09-14 | Agrospheres Inc | Composiciones y metodos para la produccion y la administracion expansible de productos biologicos. |
| MX2021006977A (es) * | 2018-12-12 | 2021-10-13 | Flagship Pioneering Innovations V Inc | Anellosomas y metodos de uso. |
| WO2021252955A1 (en) * | 2020-06-12 | 2021-12-16 | Flagship Pioneering Innovations V, Inc. | Tandem anellovirus constructs |
| MX2022016475A (es) * | 2020-06-17 | 2023-04-11 | Flagship Pioneering Innovations V Inc | Metodos de identificacion y caracterizacion de anellovirus y usos de los mismos. |
| CA3206361A1 (en) * | 2020-12-23 | 2022-06-30 | Flagship Pioneering Innovations V, Inc. | In vitro assembly of anellovirus capsids enclosing rna |
| US20240408241A1 (en) * | 2021-10-12 | 2024-12-12 | Flagship Pioneering Innovation V, Inc. | Novel anellovector compositions and methods |
| US20250027107A1 (en) * | 2021-10-18 | 2025-01-23 | Flagship Pioneering Innovations Vii, Llc | Dna compositions and related methods |
| WO2025080985A1 (en) | 2023-10-13 | 2025-04-17 | Flagship Pioneering Innovations V, Inc. | Tissue specific anellovector delivery |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9002008A (nl) * | 1990-09-12 | 1992-04-01 | Stichting Centr Diergeneeskund | Recombinant dna en rna en daarvan afgeleide produkten. |
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| US9676828B2 (en) * | 2010-06-23 | 2017-06-13 | Deutsches Krebsforschungszentrum | Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| KR20200038236A (ko) * | 2017-06-13 | 2020-04-10 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 큐론을 포함하는 조성물 및 그의 용도 |
| CA3119339A1 (en) * | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes for delivering intracellular therapeutic modalities |
| MX2021006977A (es) * | 2018-12-12 | 2021-10-13 | Flagship Pioneering Innovations V Inc | Anellosomas y metodos de uso. |
| BR112021009379A2 (pt) * | 2018-12-12 | 2021-08-17 | Flagship Pioneering Innovations V, Inc | anelossomos para entrega de modalidades terapêuticas secretadas |
-
2019
- 2019-12-12 WO PCT/US2019/065963 patent/WO2020123795A2/en not_active Ceased
- 2019-12-12 BR BR112021010925-0A patent/BR112021010925A2/pt unknown
- 2019-12-12 MX MX2021006945A patent/MX2021006945A/es unknown
- 2019-12-12 AU AU2019395418A patent/AU2019395418A1/en active Pending
- 2019-12-12 EP EP19836336.8A patent/EP3894569A2/en active Pending
- 2019-12-12 CA CA3119814A patent/CA3119814A1/en active Pending
- 2019-12-12 CN CN201980091248.4A patent/CN114127303A/zh active Pending
- 2019-12-12 US US17/413,297 patent/US20220073950A1/en active Pending
- 2019-12-12 JP JP2021533527A patent/JP2022513459A/ja not_active Withdrawn
- 2019-12-12 KR KR1020217021776A patent/KR20210125990A/ko active Pending
-
2021
- 2021-06-07 IL IL283781A patent/IL283781A/en unknown
-
2024
- 2024-05-07 JP JP2024075364A patent/JP2024099833A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020123795A3 (en) | 2020-08-27 |
| EP3894569A2 (en) | 2021-10-20 |
| BR112021010925A2 (pt) | 2021-08-31 |
| US20220073950A1 (en) | 2022-03-10 |
| MX2021006945A (es) | 2021-08-24 |
| AU2019395418A1 (en) | 2021-06-03 |
| JP2022513459A (ja) | 2022-02-08 |
| KR20210125990A (ko) | 2021-10-19 |
| CA3119814A1 (en) | 2020-06-18 |
| WO2020123795A2 (en) | 2020-06-18 |
| JP2024099833A (ja) | 2024-07-25 |
| CN114127303A (zh) | 2022-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283781A (en) | Analosomes for the delivery of protein replacement therapeutics | |
| IL283778A (en) | Analosomes for delivery of secreted therapeutic modalities | |
| IL276464A (en) | Methods and preparations for administering therapeutic protein | |
| GB201820166D0 (en) | Therapeutic agents | |
| SG11202104461XA (en) | Therapeutic methods | |
| GB201820165D0 (en) | Therapeutic agents | |
| SI4122464T1 (sl) | Terapevtske kombinacije za zdravljenje bolezni jeter | |
| IL283771A (en) | Analosomes for the delivery of intracellular therapeutic modalities | |
| IL290675A (en) | Medical protein concentrates | |
| IL279685A (en) | Gene therapy | |
| GB201805816D0 (en) | Therapeutic agents | |
| GB201707212D0 (en) | Gene therapy for ciliopathies | |
| IL273929A (en) | Therapeutic agents for neurodegenerative diseases | |
| ZA201902689B (en) | Therapeutic protein | |
| GB201802326D0 (en) | Gene therapy | |
| IL275613A (en) | Gene therapy for eosinophilic disorders | |
| IL275690A (en) | Nanoparticles for targeted delivery of therapeutic polypeptides | |
| GB201909493D0 (en) | Therapeutic interactions | |
| GB201817470D0 (en) | Gene therapy | |
| HK40053319A (en) | Anellosomes for delivering protein replacement therapeutic modalities | |
| GB201817469D0 (en) | Gene therapy for retinal disease | |
| HK40053701A (en) | Anellosomes for delivering secreted therapeutic modalities | |
| HK40052985A (en) | Anellosomes for delivering intracellular therapeutic modalities | |
| GB201805554D0 (en) | Therapy for protein misfolding disease | |
| GB201820162D0 (en) | Therapeutic agents |